tiprankstipranks
Trending News
More News >
Xebra Brands Ltd. (TSE:XBRA)
:XBRA

Xebra Brands Ltd. (XBRA) AI Stock Analysis

Compare
7 Followers

Top Page

TSE:XBRA

Xebra Brands Ltd.

(XBRA)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 4o)
Rating:49Neutral
Price Target:
Xebra Brands Ltd. scores 48.75, reflecting significant financial struggles, including high liabilities and negative cash flows. However, recent strategic corporate events, such as market expansions and regulatory achievements, provide potential growth opportunities. The technical analysis suggests upward momentum but warns of overbought conditions.
Positive Factors
Market Expansion
Entering the U.S. CBD market with a strategic partner enhances Xebra's market presence in North America, tapping into the world's largest hemp and CBD market, which is crucial for long-term growth.
Regulatory Advantage
Xebra's exclusive legal status in Mexico's regulated cannabis market provides a competitive edge, ensuring compliance and consumer trust, which is vital for sustainable growth.
European Expansion
Securing a Dutch license allows Xebra to expand its European footprint, leveraging the Netherlands' regulatory framework for cannabis, which can drive long-term strategic growth.
Negative Factors
Financial Instability
Persistent financial instability, marked by negative cash flow and declining equity, poses a risk to Xebra's ability to sustain operations and invest in growth opportunities.
Negative Cash Flow
Ongoing negative cash flow highlights liquidity challenges, limiting Xebra's capacity to fund operations and strategic initiatives, potentially hindering long-term growth.
Unprofitability
Continued unprofitability, reflected in negative profit margins, undermines Xebra's financial health, affecting its ability to reinvest in business development and expansion.

Xebra Brands Ltd. (XBRA) vs. iShares MSCI Canada ETF (EWC)

Xebra Brands Ltd. Business Overview & Revenue Model

Company DescriptionXebra Brands Ltd. engages in the cultivation, processing, manufacturing, design, and delivery of cannabis products in Canada. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers its products under the HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle brands. Xebra Brands Ltd. was incorporated in 2019 and is headquartered in Vancouver, Canada.
How the Company Makes MoneyXebra Brands Ltd. generates revenue through the cultivation, production, and sale of cannabis products. The company's primary revenue streams include the sale of cannabis flowers, oils, and infused products to both medical and recreational consumers. Xebra Brands also engages in licensing agreements and partnerships that allow it to expand its market reach and product offerings. By securing strategic partnerships with local and international distributors, the company enhances its ability to enter new markets and drive sales. Additionally, Xebra Brands invests in research and development to innovate and improve its product line, aiming to capture a larger share of the growing cannabis market.

Xebra Brands Ltd. Financial Statement Overview

Summary
Xebra Brands Ltd. is experiencing significant financial challenges, including unprofitability, declining equity, and negative cash flows. The company struggles with revenue generation and maintaining a stable financial structure.
Income Statement
Xebra Brands Ltd. has consistently faced challenges in generating revenue, with the most recent TTM (Trailing-Twelve-Months) revenue at a mere $1. The company has negative gross and net profit margins, indicating unprofitability. Despite a significant reduction in EBIT and EBITDA losses from previous periods, the company struggles to cover its operating costs.
Balance Sheet
The company's balance sheet shows a high level of liabilities compared to equity, resulting in a negative stockholders' equity in recent years. With no debt, the debt-to-equity ratio is not applicable, but the low equity indicates financial instability. The equity ratio has significantly decreased, reflecting the eroding asset base.
Cash Flow
Xebra Brands Ltd. has negative operating and free cash flows, indicating continuing cash burn without sufficient revenue generation. The recent reduction in negative cash flow is a positive sign, but the operating cash flow to net income ratio remains unfavorable, highlighting ongoing liquidity challenges.
BreakdownTTMDec 2023Dec 2022Dec 2021Dec 2021Dec 2019
Income Statement
Total Revenue0.00106.86K158.95K0.000.000.00
Gross Profit-324.46K-308.42K-16.03K-550.31K-603.37K-11.78K
EBITDA-1.60M-1.49M-2.82M-1.32M-3.93M-2.78M
Net Income-1.97M-1.96M-4.02M-1.86M-6.14M-2.79M
Balance Sheet
Total Assets431.44K379.37K1.32M3.60M1.32M5.14M
Cash, Cash Equivalents and Short-Term Investments7.77K102.42K202.29K93.33K202.29K955.41K
Total Debt0.000.000.0067.03K28.79K321.27K
Total Liabilities638.28K789.96K772.16K618.85K772.16K610.72K
Stockholders Equity53.67K-154.52K795.67K3.00M795.67K4.54M
Cash Flow
Free Cash Flow-416.82K-827.56K-2.39M-1.06M-2.39M-2.28M
Operating Cash Flow-416.82K-827.56K-2.32M-911.32K-2.32M-1.96M
Investing Cash Flow0.000.00-63.63K-145.28K-63.63K-1.57M
Financing Cash Flow322.33K722.64K1.94M201.60K1.94M4.48M

Xebra Brands Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.01
Price Trends
50DMA
<0.01
Positive
100DMA
0.01
Negative
200DMA
0.03
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
32.40
Neutral
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XBRA, the sentiment is Negative. The current price of 0.01 is above the 20-day moving average (MA) of <0.01, above the 50-day MA of <0.01, and below the 200-day MA of 0.03, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 32.40 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:XBRA.

Xebra Brands Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
C$420.72K-0.31
42
Neutral
C$1.39M-0.48-73.82%
31
Underperform
C$2.42M-0.64563.34%-68.82%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:XBRA
Xebra Brands Ltd.
0.01
-0.04
-80.00%
TSE:WIB
West Island Brands Inc
0.13
0.00
0.00%
TSE:CFT
Craftport Cannabis Corp
0.05
0.00
0.00%
TSE:VENI
Top Strike Resources
0.01
0.00
0.00%
TSE:AION
Aion Therapeutic Inc
0.01
-0.01
-50.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 29, 2025